LaBonne is president of the Society for Developmental Biology and the Erastus Otis Haven professor of molecular biosciences at Northwestern University. Imagine a world without lifesaving medicines, ...

In recent months, the Food and Drug Administration and National Institutes of Health have announced new initiatives to reduce and replace animal testing in biomedical research. Central to these ...

CRISPR-Cas9 technology is used to knock out or modify DNA in research mice to study disease phenotypes and develop new treatments. CRISPR mice and rats are offered by Charles River, which uses genetic ...

Animal models are established, important tools for preclinical safety and efficacy testing. Companies are advancing more “humanized” models to better reflect human responses, while at the same time ...

AI inference uses trained data to enable models to make deductions and decisions. Effective AI inference results in quicker and more accurate model responses. Evaluating AI inference focuses on speed, ...

The AI industry stands at an inflection point. While the previous era pursued larger models—GPT-3's 175 billion parameters to PaLM's 540 billion—focus has shifted toward efficiency and economic ...